In CERCLM, the overexpression of Alanine-Serine-Cysteine 2 (ASCT2) can promote the expression of αVβ3-integrin in tumor cells, and then activate the αVβ3/FAK/PI3K/AKT signal pathway, thus promoting VC (24). This evidence concerns the gene SLC1A5 and neoplasm.